证券之星消息,百洋医药(301015)06月27日在投资者关系平台上答复投资者关心的问题。投资者:尊敬的董秘您好,请问公司目前核药医学相关取得了怎么样的进展?公司作为火星舟外科机器人的独家经销商,目前在医学相关的领域获得哪些核心竞争力或者专利百洋医药董秘:投资者您好,公司运营的“锝99mTc肼基烟酰胺聚乙二醇双环RGD肽注射液”临床III期试验结果已达主要终点和次要终点;ZAP-X火星舟放射外科...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.